![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 75.00 | 73.00 | 77.00 | 75.00 | 75.00 | 75.00 | 22,023 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investment Advice | 149k | -7.14M | -0.1082 | -6.93 | 49.49M |
RNS Number:8019I Celsis International PLC 18 February 2005 Celsis International Plc 18 February 2004 Celsis International Plc ("the Company") DISCLOSURE OF INTEREST IN SHARES Celsis International Plc received notification on 17 February 2005 that Barclays Plc has a notifiable interest in 4,156,851 Ordinary Shares in the Company representing 3.71 per cent. of the total issued share capital of the Company, as detailed below: Registered Holder Holding % JP Morgan (BGI CUSTODY) 16341 164,320 0.15 JP Morgan (BGI CUSTODY) 16344 66,864 0.06 JP Morgan (BGI CUSTODY) 16345 88,733 0.08 JP Morgan (BGI CUSTODY) 16480 3,822,009 3.41 RC Greig Nominees Limited a/c CM1 7,000 0.01 Reflex Nominees Limited 7,925 0.01 Total 4,156,851 3.71 ENDS This information is provided by RNS The company news service from the London Stock Exchange END HOLUWONRVARUAAR
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions